密理博---MILLIPORE

音标 Phonetic symbol

[ 'milip>:]　 词性及解释 Part of speech and definition

【医】微孔

【化】 微孔过滤

在美国密理博(MILLIPORE)，我们专注于帮助我们的客户解决世界上最具挑战的人类健康问题 。作为生命科学行业的领头羊，我们为生命科学研究和生物制药生产提供多种学科的专业指导和全面的前沿技术、工具和服务。从我们的CEO到我们的客户服务代表，我们的员工对工作都充满热情。我们和客户一起携手针对难题开发个性化的解决方案，在现在和将来确保科学实验的顺利进行。密理博公司是标准普尔500指数成分股之一，现有员工超过6000人，遍布全球47个国家。

Advancing Life Science Together™

Research.Development.Production.

公司总部

Millipore Corporation

290 Concord Road

Billerica, MA 01821

Tel: 978-715-4321

公司创建时间: 1954

上市地点和代号:NYSE: MIL

2006年营业额: .26 billion

员工总数: 6,100 worldwide

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees in 47 countries worldwide.

In 1954, a recent college graduate named Jack Bush started a membrane company that over the next 50 years would grow from a handful of employees to a multi-national bioscience corporation with more than 5,800 employees and annual sales of .3 billion. Over the years, this small company that pioneered the use of membrane technology in hundreds of diverse applications grew not only in size and sales but also in scientific capability. Through substantial R&D investments, strategic acquisitions and international expansions, Bush’s company broadened its technology and market base to become a leader in the life science industry serving biotechnology firms, pharmaceutical companies and laboratories around the world.

In the early 1950s Bush was working for the Lovell Chemical Company, a small (20 person) privately owned business just outside of Boston. One day, Lovell’s owner was approached by the U.S. Army Chemical Corps and asked to bid on a contract to develop and manufacture membrane-based filtering devices and systems used to separate the molecular components of fluid samples.

Beating out such giants as Eastman Kodak and DuPont for the government contract, this little company set to work successfully developing membranes first used in Germany after World War II, when saturation bombing resulted in widespread water contamination.

When the membranes were declassified in 1953 and offered for commercial use, Bush bought Lovell Chemical’s right to the technology for 0,000. Other companies declined to bid for the rights to this membrane technology. They believed that there was no commercial future for the membrane filter. As a result, Bush established what he called the Millipore Filter Company, named for a sponge that lives by osmosis in the Adriatic Sea. The name was later changed to Millipore Corporation to reflect its wide range of products for fluid analysis and purification.

In its early years, Millipore made some major contributions to water microbiology methods that have become part of the standard of the US Public Health Service. “The membrane technology was revolutionary in terms of giving researchers and scientists the basic tools they needed,” Bush told an interviewer in the late 1990s. “We were on the cutting edge.” Separation technologies and products were needed not only by researchers, but also by medical schools, hospitals and dialysis centers, and many industries – including the pharmaceutical, chemical, plastics, food and beverage, and microelectronics industries.

Soon after starting the company, Bush aggressively pursued new markets by establishing distributorships around the world. This was a very risky move: “I guess we believed in the bold stroke,” he reflected several years before his retirement in 1992. “We could have conserved our resources, but we decided to go hell-bent in all directions. And happily, we were lucky!” Canada was the first in 1959 and by 1961 there were distributors and sub-agents in Greece, Italy, Spain, Portugal, England, Australia, the Scandinavian countries and Switzerland. The distributorships were so successful that Bush established subsidiaries in seven countries by the end of the decade.

The company continued to expand, opening manufacturing plants in Jaffrey, New Hampshire, Molsheim France and Cork Ireland to meet the growing demand for its worldwide products.

In 2004, the company celebrated its 50th anniversary. The company continues to grow and has acquired several companies during the past few years, including NovaSeptic AB, Microsafe B.V., and Newport Biosystems.

In 2006, Millipore Corporation acquired Serologicals Corporation, a Georgia-based corporation doing business as the companies Chemicon, Upstate, Linco and Celliance. These companies provide products and services to researchers at major life science companies and leading research institutions involved in: neurology, oncology, hematology, immunology, cardiology, infectious diseases, cell signaling and stem cell research.

By integrating Serologicals’ products and services into our capabilities, Millipore has become the only company in the Life Science industry that offers both upstream cell culture and downstream separation offerings for biopharmaceutical production. The acquisition also gave Millipore leading positions in a broad range of high growth segments such as drug discovery products and services, antibodies, cell biology reagents, and stem cell research. Formerly, Serologicals products were not widely available in international markets, so Millipore’s significant presence in Europe, Asia and Japan will lead to increased sales of these products. Our customers’ research will benefit because Millipore is now able to optimize workflows from sample preparation, to developing and performing assays, to analyzing results.

With offices in more than 47 countries worldwide and more than 6,000 employees, the company is committed to helping solve the world’s challenging human health issues. Today, Millipore is a leader in the life science industry, providing scientific expertise and a full-range of products and services from concept to production.

Millipore Corporation

290 Concord Road

Billerica, MA 01821

Tel: 978-715-4321

-----可为以下行业提供专业的产品和解决方案

生命科学

药物研发

样品制备

实验室纯水

工艺优化

生物制品

生产过程的微生物检测

--------------

具体分类如下:

临床诊断&传染性疾病

干细胞生物学

抗体&免疫检测

神经科学

细胞信号传导&表观遗传学

细胞生物学

蛋白质研究

过滤&样品制备

制药产品分析

水相及有机溶液过滤

液体监测及工业质量控制

环境检测和分析

色谱和质谱样品制备

食品及饮料分析

水纯化服务

水纯化系统 -反渗透水

水纯化系统 -纯水

水纯化系统 -超纯水

水纯化耗材

水纯化配件

传统制药

单抗 & 重组制品

疫苗

血清&血浆

饮料

制药企业QA

医院药房

微电子行业

产品类型

对照片

Pod 过滤器

RNAi 产品

TFF 装置和系统

一次性使用装置

分析

动物血清

印迹膜

卷缩机

取样板&取样棉签

吸液器吸管

囊式滤器

圆片滤膜

多元设备

多孔滤膜板

套筒

完整性测试仪

密封

层析产品-生物制品

工艺储罐

带菌量检测产品

微滤产品

微生物检测产品

快速微生物检测系统

抑制剂

抗体

抽真空设备

抽真空设备配件

换膜式过滤器和附件

接头&取样口

搅拌器

搅拌式过滤器

支原体测试产品

无菌取样系统

无菌检测产品

有毒废物检测装置

检测装置

水样检测产品

水纯化服务

水纯化系统-III级水 （反渗透水）

水纯化系统-II级水 （纯水）

水纯化系统-I级水 （超纯水）

水纯化耗材

水纯化附件

深层滤器

溶解产物（溶菌）

澄清产品

灌装设备

环境检测产品

生物制品服务

盒式/模块式

离心过滤单元

空气微生物检测产品

筒式滤器

细胞培养和诊断产品

细胞培养装置

细胞培养设备和配件

细胞培养试剂

细胞系

细菌培养皿和含垫片培养皿

细菌检测产品

蛋白质&酶

试剂

试剂盒

质粒

超滤产品

超滤膜

过滤系统

过滤膜

过滤装置

过滤装置和附件

过程检测服务

针头式过滤器

除病毒装置

除菌滤器

静态浓缩器

预滤器